Literature DB >> 31269374

Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.

Deepak P Chander1, Michelle M Loch1, Spero R Cataland2, James N George3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31269374     DOI： 10.1056/NEJMc1905426

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP.

Authors:  Linus A Völker; Jessica Kaufeld; Wolfgang Miesbach; Sebastian Brähler; Martin Reinhardt; Lucas Kühne; Anja Mühlfeld; Adrian Schreiber; Jens Gaedeke; Markus Tölle; Wolfram J Jabs; Fedai Özcan; Silke Markau; Matthias Girndt; Frederic Bauer; Timm H Westhoff; Helmut Felten; Martin Hausberg; Marcus Brand; Jens Gerth; Markus Bieringer; Martin Bommer; Stefan Zschiedrich; Johanna Schneider; Saban Elitok; Alexander Gawlik; Anja Gäckler; Andreas Kribben; Vedat Schwenger; Ulf Schoenermarck; Maximilian Roeder; Jörg Radermacher; Jörn Bramstedt; Anke Morgner; Regina Herbst; Ana Harth; Sebastian A Potthoff; Charis von Auer; Ralph Wendt; Hildegard Christ; Paul T Brinkkoetter; Jan Menne
Journal:  Blood Adv       Date:  2020-07-14

2.  Immune-mediated thrombotic thrombocytopenic purpura in a Jehovah's Witness - Effectiveness of incorporating extracorporeal immunoadsorption to caplacizumab, steroids and rituximab.

Authors:  Teresa Marta Cardesa-Salzmann; Bernhard Stephan; Arne Simon; Rhoikos Furtwängler; Dominik Schöndorf; Sabine Heine; Eyad Torfah; Margaux Lux; Sonja Meyer; Norbert Graf
Journal:  Clin Case Rep       Date:  2022-05-20

3.  Comparison of the efficacy and safety of caplacizumab versus placebo in thrombotic thrombocytopenic purpura: a meta-analysis and systematic review based on randomized controlled trials.

Authors:  Bin Chen; Xihong Li; Dongqiong Xiao; Rodrigo Daminello Raimundo; Ruixi Zhou; Yupeng Lei
Journal:  Ann Transl Med       Date:  2022-06

4.  Thrombotic thrombocytopenic purpura masquerading as preclampsia with severe features at 13 weeks' gestation.

Authors:  Eric J Avery; Sean P Kenney; Benjamin D Byers; Jennifer J McIntosh; Christopher Hoover; Yizhi Jiang; Lijun Xia; Zhongxin Yu; James N George
Journal:  Am J Hematol       Date:  2020-06-29       Impact factor: 10.047

5.  Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.

Authors:  Linus A Völker; Jessica Kaufeld; Wolfgang Miesbach; Sebastian Brähler; Martin Reinhardt; Lucas Kühne; Anja Mühlfeld; Adrian Schreiber; Jens Gaedeke; Markus Tölle; Wolfram J Jabs; Fedai Özcan; Silke Markau; Matthias Girndt; Frederic Bauer; Timm H Westhoff; Helmut Felten; Martin Hausberg; Marcus Brand; Jens Gerth; Markus Bieringer; Martin Bommer; Stefan Zschiedrich; Johanna Schneider; Saban Elitok; Alexander Gawlik; Anja Gäckler; Andreas Kribben; Vedat Schwenger; Ulf Schoenermarck; Maximilian Roeder; Jörg Radermacher; Jörn Bramstedt; Anke Morgner; Regina Herbst; Ana Harth; Sebastian A Potthoff; Charis von Auer; Ralph Wendt; Hildegard Christ; Paul T Brinkkoetter; Jan Menne
Journal:  Blood Adv       Date:  2020-07-14

Review 6.  Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist.

Authors:  Juliana Perez Botero; Jessica A Reese; James N George; Jennifer J McIntosh
Journal:  Am J Hematol       Date:  2021-09-04       Impact factor: 10.047

7.  Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab.

Authors:  Senthil Sukumar; James N George; Spero R Cataland
Journal:  Am J Hematol       Date:  2020-01-14       Impact factor: 13.265

Review 8.  The standard of care for immune thrombotic thrombocytopenic purpura today.

Authors:  X Long Zheng
Journal:  J Thromb Haemost       Date:  2021-06-30       Impact factor: 16.036

Review 9.  Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease.

Authors:  Prajeeda M Nair; Matthew J Rendo; Kristin M Reddoch-Cardenas; Jason K Burris; Michael A Meledeo; Andrew P Cap
Journal:  Semin Hematol       Date:  2020-07-27       Impact factor: 3.851

Review 10.  Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura.

Authors:  Ashley Hanlon; Ara Metjian
Journal:  Ther Adv Hematol       Date:  2020-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.